Skip to main content
. 2021 Jun 8;2021:5567332. doi: 10.1155/2021/5567332

Figure 1.

Figure 1

Frequency of HIV-1 drug resistance mutations according to inhibitor class and TAMs detected in 82 individuals. (a) DRM to NRTI: nucleoside reverse transcriptase inhibitors (91.5%, n = 75/82). (b) DRM to NNRTI: nonnucleoside reverse transcriptase inhibitor (84.1%, n = 69/82). (c) DRM to PI: protease inhibitors (17%, n =14/82). (d) Thymidine analog mutations TAM [TAM-1 (n = 14), TAM-2 (n = 17)].